A rapid and sustained increase in the number of microbodies in liver and kidney cells can be induced in male rats by ethyl chlorophenoxyisobutyrate (CPIB), a hypolipidemic drug. This phenomenon permits investigation of several aspects of microbody behavior in experimental conditions. Reversal experiments demonstrate that liver cells revert to normal between 2 and 3 weeks after withdrawal of CPIB and that one of the mechanisms for removal of excess microbodies is their incorporation into structures indistinguishable from lysosomes. In a state of rapid cell division, such as that present during liver regeneration, microbody proliferation apparently occupies a high biological priority. In necrotic or degenerating cells microbody structure remains relatively normal. The increase in microbodies induced by CPIB is inhibited by chloramphenicol. No increase in microbodies occurred in female rats or in chickens, guinea pigs, or rabbits at the dosage used (0.25% in diet). No changes in microbodies were seen in monkey liver. Catalase activity was generally parallel to the numerical response in microbodies. Additional observations suggest that the microbody response to CPIB is not related to hepatomegaly induced by this agent but may be related to the hypolipidemic effect of CPIB, though hypolipidemia per se is not a specific or sufficient cause of microbody proliferation.
INTRODUCTION
Microbodies constitute a distinct class of cytoplasmic organelles, of relatively recent morphological and biochemical characterization, in hepatic and renal cells of several vertebrates including man, and in the protozoan, Tetrahymena pyriformis (1, 2) . De Duve and his coworkers showed that these organelles possess several enzymes capable of production and catabolism of hydrogen peroxide (3) and termed them "peroxisomes" to indicate their biochemical potential (4) . By electron microscopy, microbodies are identified by several characteristics. In the rodent liver, they are approximately 0.5 Ap in diameter, circular in thin sections, limited by a single membrane, contain a homogeneous matrix of moderate electron opacity, and possess, in many species, a nucleoid or core of greater density than the surrounding matrix. The nucleoid may be absent or, if present, either of a highly ordered crystalline pattern or lacking a specific, organized structure. In many vertebrates, the shape and ultrastructure of the nucleoid is characteristic of and constant within the species (5) .' A number of morphological variations in renal microbodies of normal rats have been reported by Ericsson and Trump (6) .
The role of microbodies in cell physiology is not known, and comparatively little attention has been paid to their pathologic reactions, especially in species other than rodents. Morphologically, these organelles appear comparatively unresponsive to most experimental conditions, and, with few exceptions (7) (8) (9) (10) (11) (12) , alterations in microbodies have been reported infrequently or only incidentally.
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at each interval. Samples of kidney were that microbodies become altered in size, shape, number, and in enzyme content after the administration of ethyl -p -chlorophenoxyisobutyrate (clofibrate, CPIB), a hypolipidemic agent which lowers serum cholesterol and triglycerides in man (15) and in experimental animals (16, 17 To compare the effects of CPIB with those of other hypolipidemic agents, male rats of CFE strain, weighing between 100 and 140 g, were given the agents listed in Table II. To discover the species range of response of hepatic microbodies to CPIB, we studied samples of liver from the following animals. (a) C 3 H male mice were given 0.25% CPIB in ground Chow diet. Two mice were killed at 9, 11, and 14 days; four were killed at 1 month and 5 months. (b) Two hamsters, two guinea pigs, and two rabbits (all males) were Furthermore, the differences in microbody response to CPIB in several species was studied as a preliminary attempt to clarify the relationship of the microbody-inducing effect of CPIB to other properties of this agent.
MATERIALS AND METHODS

Experiments on Rat Liver with CPIB
For electron microscopic study of rat liver, the distribution of animals, experimental manipulations and time when killed are indicated in Table I . All rats used were F-344, weighing between 126 and 262 g. The basal diet consisted of ground Purina Chow to which CPIB was added prior to thorough mechanical mixing. The thrombogenic diet had the given 0.25% CPIB in suitable laboratory diet and killed at 14 days. (c) Two white leghorn cocks were fed 0.25% CPIB and killed at 3 wk. (d) One male South American squirrel monkey (Saimiri sciurea), weighing approximately 2 kg, was force-fed CPIB (75 mg/kg) daily and killed at 22 days. (e) One male mongrel dog was given CPIB (25 mg/kg) daily and killed at 26 days. With each species, liver from one of two controls was studied.
Light and Electron Microscopic Methods
For light microscopy, samples of tissue were fixed in neutral buffered formaldehyde, embedded in paraffin, and sections were stained with hematoxylin and eosin. For electron microscopy, tissues were fixed for 1-2 hr in 2% osmium tetroxide buffered with s-collidine or in phosphate-buffered glutaraldehyde, dehydrated in a graded series of alcohols and embedded in epoxy resin. Thin sections were cut on an LKB 8800A ultramicrotome equipped with glass or diamond knives, stained with lead or uranyl acetate, and examined in an RCA 3G electron micro-scope employing a 35-40 objective aperture and an accelerating voltage of 50 kv. For orientation of blocks prepared for electron microscopy, semi-thin sections (0.5 1.5 it) were stained with azure A in sodium bicarbonate and examined by light microscopy.
Biochemical Methods
In groups 1, 4, 5, and 7 through 11 (Table I) , as well as in mice on CPIB for 4 months, samples of liver were taken for determination of catalase and uricase activity. Catalase activity was determined by the spectrophotometric method described by Lick (18) , using a 24-hr extraction. Uricase activity was assayed according to the procedure of London and Hudson (19) . Protein was determined by the Lowry method (20) . Determinations of enzyme activity were done in duplicate. For total liver lipids in animals fed a thromnbogenic diet, the livers were dried to constant weight, extracted with ethanolether (3:1), reweighed, and lipids were determined by weight difference.
RESULTS
Light Microscopy
In hematoxylin and eosin stained sections of paraffin-embedded liver of male rats treated with CPIB, the architecture appeared normal. The cells, however, were of greater than normal diameter and this increase appeared to be solely the result of an increase in cytoplasm. In many cells, at random throughout the lobules, cytoplasmic basophilia was decreased and replaced by eosinophilic, granular areas. In osmium tetroxide-fixed, Epon-embedded blocks of liver stained with azure-bicarbonate and examined with orange or red filters, microbodies were evident as numerous dark, sharply punctate dots which were denser, smaller, and more uniformly circular than mitochondrial contours (Figs. 1-3 ). Nuclei and nucleoli appeared normal Electron Microscopy BASIC EXPERIMENT. GROUPS 1, 2, AND 3 (TABLE I) GROUP 1: No changes in number or structure of microbodies were apparent at 12 hr. The changes in male liver after feeding CPIB for 3-30 days consisted of marked increase in the number of microbodies, first apparent at 3 days and sustained thereafter (Fig. 4) . A large proportion of microbodies were abnormal in size and (Fig. 1) , the number of microbodies (arrows) is increased appreciably. Microbodies are round, dense, and distinct (Fig. 3) , compared with the mitochondria which are faint and have indistinct margins. The increase in microbodies is apparent throughout the entire cytoplasm. Although microbodies cannot be distinguished unequivocally from lysosomes or peribiliary dense bodies by this technique, the generalized increase in circular densities in all parts of the cytoplasm (not limited to peribiliary areas), the absence of detectable increase in the number of lysosomes as shown by electron microscopy or in biochemical determinations of acid phosphatase activity 4 as well as by comparison to Fig. 4 (an electron micrograph taken from the same liver)
indicate that most, if not all, of the circular densities are microbodies. shape, their matrix contained linear striations, and many lacked nucleoids. Variation in matrix density and continuity of the limiting membrane with smooth ergastoplasmic membranes were frequently seen. After 30 days, there was no further increase in number of microbodies in animals that remained on CPIB, although, by 6 wk, atypical forms appeared to be more numerous than previously (Figs. 5, 6 ). In addition, there was conspicuous increase in vesicles of smooth endoplasmic reticulum ( Fig. 7) . At 8 wk, the increased number of microbodies as well as increased smooth endoplasmic reticulum persisted. Many ill defined diffuse densities, not clearly limited by a membrane at their entire periphery, were present ( Fig.  8) , and continuity of microbodies with vesicles of smooth endoplasmic reticulum was conspicuous (Fig. 9) . Occasionally, roughly rectangular areas with the density of microbodies were connected by narrow, tubular channels ( Fig. 10 ).
At 10 wk, there were many small, irregularly shaped structures resembling microbodies in density ( Fig. 11 ), frequently located near large, more nearly normal microbodies. Many lacked a limiting membrane about their entire periphery; instead, a portion of their matrix was disposed as a diffuse, ill defined density in the hyaloplasm (Figs. 11, 12) .
At all intervals, there were no conspicuous or uniform changes in mitochondria. A few showed elongation and flattening with close apposition of limitingmembranes. In others, there were membrane-limited collections of fibrils (Fig. 13 ).
GROUP 2: In animals fed CPIB at a lower concentration (0.1%) in the diet, there was no apparent increase in the number of microbodies nor alterations in their structure at 3 and 10 wk.
GROUP 3: Female F-344 rats given 0.25% CPIB in their diet and sacrificed at 2 and 4 wk showed neither an increase in microbodies nor FIGuRE 4 Male rat liver. CPIB, 20 days. Numerous microbodies (mb) are evenly distributed throughout the cytoplasm. While most do not have well defined nucleoids, a few contain small eccentric densities (n). Mitochondria (mi) are normal. X 11,000.
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FIGURE 5 Male rat liver. CPIB, 6 wk. In the center, an unusual form of microbody (nb) is seen. Near the end of the straplike extension, a protuberant density resembling a nucleoid (n) is apparent. Continuity with an agranular vesicle is seen at the arrow. X 66,000. structural abnormalities in these organelles although vesicles of smooth endoplasmic reticulum were slightly increased.
GROUPS 4 AND 5; REVERSAL
Microbodies were increased in number to the same extent in rats given 0.25% CPIB for 4 and 8 wk (Table I , groups 4 and 5, respectively). At I wk after withdrawal of CPIB and restoration to a normal Chow diet, the increase persisted. By 2 wk, there appeared to be a variable decrease from cell to cell in the number of microbodies. Three wk after restoration to a normal diet, however, liver cells appeared normal in both groups with respect to microbodies although vesicles of smooth endoplasmic reticulum were relatively abundant (Fig. 14) .
In rats restored to a normal diet after 4 and 8 wk on CPIB (groups 4 and 5), and to a lesser extent in those maintained on 0.25% CPIB for 10 and 21 wk (group 1), there was segregation of microbodies within single membrane-limited cytoplasmic structures which usually contained small amounts of other cytoplasmic material (Fig. 15) . Typically, these bodies were roughly circular with an average diameter of 0.5 , limited by a single membrane and containing, in addition to ergastoplasmic membranes, glycogen and ribosomes, microbodies possessing characteristic matrix density and, occasionally, a nucleoid ( Fig. 16 ). Certain structural variations were apparent. Interruptions in the limiting membrane (Fig. 17) or the appearance of multiple encircling membranes as a result of the close apposition of collapsed ergastoplasmic membranes to the outer contour of the limiting membrane were noted. Frequently, like many microbodies free in the cytoplasm, the captive microbody lacked a nucleoid. The number of single membrane-limited structures containing microbodies in any given section of liver was small. Several cells had none. 
Inhibition of CPIB Effect on Microbodies
Two per cent chloramphenicol in the diet (group 6) fed concomitantly inhibited the effect of CPIB on microbodies. Sections of liver from CPIB-treated rats given chloramphenicol were indistinguishable from those of liver from rats given chloramphenicol only (group 7); the most conspicuous abnormality consisted of mitochondrial enlargement and a moderate increase in smooth endoplasmic reticulum.
The effect of aflatoxin B (0.45 mg/kg intraperitoneally twice a week for 4 wk) on microbody formation in CPIB-treated rats (groups 8 and 9) was not as conclusive as that of chloramphenicol. In most cells, the number of microbodies appeared normal, but in some there was an obvious increase in their number. Actinomycin D, in a dose of 8 pg/kg three times per week for 8 wk (group 10), only partially inhibited the CPIB effect on microbodies and on liver weight whereas a higher dose (10 g/kg per wk, group 11) completely inhibited the CPIB effect.
Thrombogenic Diet
In rats given a thrombogenic diet, there was no detectable increase in microbodies after 2 wk of CPIB administration followed by thrombogenic diet and CPIB for 1 wk (group 14), or when thrombogenic diet and CPIB were administered together for 1 month (group 15). In both groups fed thrombogenic diet, however, the large number and size of fat vacuoles rendered quantitative estimation of microbodies difficult.
Regeneration
In rats given CPIB for 15 days, subjected to partial hepatectomy on the 7th day and killed 8 days later (group 17), the cells of regenerating liver contained large numbers of microbodies 134 THE JOURNAL OF CELL BIOLOGY VOLUME 35, 1967 which almost always lacked nucleoids. Close topographical association of microbodies with the few available and rudimentary cisterns of smooth or partially granulated strands of endoplasmic reticulum was a prominent feature in regenerating liver (Fig. 18) .
Necrosis
In rats fed CPIB for 7 wk and given carbon tetrachloride 24 hr prior to sacrifice (group 18), there were extensive dilatation of endoplasmic reticulum and cell necrosis but there was no clear cut evidence for the mechanism of disposal or destruction of microbodies in necrotic cells. In cells showing extensive nuclear and cytoplasmic injury, especially involving endoplasmic reticulum, microbody structure remained relatively intact (Fig. 19) .
Additional Hypolipidemic Agents
In rats given SC-12937 (20, 25-diazacholesterol), benzmalacene, BNBC (benzyl-N-benzyl carbethoxy hydroxamate), dextran, Caperase (bovine hepatocatalase), or 2,4 -dichlorophenoxyacetic acid, there was no discernible increase in number of microbodies nor abnormalities in their structure. After certain agents, notably BNBC, there were conspicuous amounts of smooth endoplasmic reticulum.
Comparison of Species' Response to CPIB
At 9-14 days, male C 3 H mice given 0.25% of CPIB showed a slight increase in hepatic microbodies and there was moderate increase in vesicles of smooth endoplasmic reticulum. In serial sections small vesicles, indistinguishable from smooth endoplasmic reticulum, contained deposits of a density similar to that of a microbody matrix (Fig. 20) . Connections of the limiting membrane of microbodies to membranes of smooth endoplasmic reticulum were apparent. From 1 to 5 months, the increase in microbodies was uniform in all cells examined (Fig. 21 ), but no additional changes were observed. In dogs and hamsters the number of microbodies appeared increased in most cells. In the latter species, there were additional structural features not evident in other groups. While moderate structural variation in microbodies was apparent in normal hamsters, this variation was markedly accentuated by the feeding of CPIB. Microbodies often had elongated profiles with tail-like extensions (Figs. 22, 23 ) or a bulbous extension giving a bipartite appearance. Occasionally, two ovoid portions were joined by a tubular connection. In those cells in which lipid globules were present, microbodies were closely apposed to the periphery of the globule (Fig. 24) .
In the livers of guinea pigs, chickens, rabbits, and squirrel monkeys there were no detectable changes in microbodies at the dose used but the amount of smooth endoplasmic reticulum was increased to variable degrees. In Rhesus monkeys the hepatic microbodies commonly have a small nucleoid or none, 2 but in squirrel monkeys they contain an irregular linear or angular nucleoid (Fig. 25) .
Kidney
In rats, at 8-10 wk, renal microbodies were increased most prominently in basal portions of some proximal tubular epithelial cells. In contrast to hepatic microbodies, most renal microbodies contained a central or paracentral faint and illdefined density resembling a nucleoid (Fig. 26) . The limiting membrane of microbodies was fre-2 D. Svoboda, 1966 . Unpublished observations.
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T E JOURNAL OF CELL BIOLOGY VOLUME 35, 1967 FIGURES 11 and 12 Male rat liver. CPIB, 10 wk. In a single plane of section are many areas with a density (d) identical with that of microbodies, which instead of being circular and confined throughout their periphery by a membrane, appear to have diffuse extensions into the hyaloplasm. A segment of the periphery is, however, limited by a membrane (m). Fig. 11 , X 28,800; Fig. 12 , X 118,000. 138 THE JOURNAL OF CELL BIOLOGY VOLUME 35, 1967 FIGURE 15 Male rat liver. CPIB, 8 wk, followed by I wk of restoration to a normal diet. A microbody (mb) is present within a single membrane-limited cytoplasmic structure which also contains glycogen (g) and vesicles of endoplasmic reticulum. X 88,000.
FIGURE 16 Male rat liver. CPIB, 8 wk, followed by I wk of restoration to a normal diet. A microbody (mb) with an eccentric, dense nucleoid (n) is present within a single membrane-limited structure. X 72,000.
quently continuous with vesicles of smooth endoplasmic reticulum. Linear striations were not present in the matrix of renal microbodies nor were they observed in hepatic microbodies of any species other than rats. They were not apparent in microbodies within lysosomes.
Biochemical Results
The results of the determination of catalase activity in livers of selected groups of animals are shown in Tables III and IV. In general, the catalase activity corresponded quite closely to the increase in microbodies (Table  III) . By 10-20 days of CPIB feeding, the catalase activity was elevated but did not continue to rise thereafter; at 30 days, the level fell slightly from that at 20 days. Upon removal of CPIB from the diet for 1, 2, and 3 wk, the levels of activity fell appreciably. By 2 wk' reversal, the catalase activity was virtually restored to normal. The lower dose of actinomycin D alone inhibited catalase activity but this inhibition was markedly offset by the addition of CPIB. With the higher dose of actinomycin D, on the other hand, the inhibitory effect was only partially offset by the administration of CPIB. Inhibition of catalase activity by aflatoxin B1 alone was not so marked as with actinomycin D and was significantly reversed by the addition of CPIB. Thrombogenic diet, by itself, lowered the catalase activity appreciably and addition of CPIB before or during the hypercholesterolemic state produced by feeding thrombogenic diet did not increase catalase activity. In male mice, catalase activity increased markedly at 5 months of feeding 0.25% CPIB (Table IV) .
D. SVoBODA, H. GRADY, AND D. AZARNOFF Microbodies in Altered Cells
FIGURE 17 Male rat liver. CPIB, 21 wk. A microbody (mb) with an irregular crescentic profile is enclosed within a single remnibrane-limited structure. Within the Golgi area (gpa) several vesicles (arrows) have an interior density resembling that of microbodies free in the cytoplasm. X 66,000.
Uricase activity followed no definite pattern and showed little or ro correlation with liver weight, microbody response, or catalase activity. Results were so variable as to render it impossible to make meaningful comparisons even among related experimental groups.
Liver Weight
In the basic experiment, the liver weight, expressed as per cent body weight, increased significantly in animals given CPIB. Hepatomegaly was apparent on gross inspection and, microscopically, appeared to be primarily due to an increase in cell size although the possibility of some increase in number of cells cannot be excluded since estimation of DNA/g wet weight of liver was not done. Removal of CPIB from the diet was accompanied by significant decrease in liver weight by 1 wk and further decreases with near restoration to normal after 2-and 3-wk reversal. In the basic experiment and reversal groups therefore, the liver weights were roughly parallel to changes in catalase activity (Table III) . In the inhibition experiments, there was appreciable increase in liver weight of rats given CPIB plus aflatoxin B 1 . With actinomycin D alone, no increase in liver weight was noted but, with the addition of CPIB to both dose levels of actinomycin, the liver weight increased appreciably. Thrombogenic diet alone was accompanied by an increase in liver weight; CPIB given concomitantly caused a slightly greater increase.
DISCUSSION
In general, few changes have been noted in hepatic microbodies in most pathological conditions, but Hruban and co-workers have described alterations in the matrix and increase in number and size following administration of salicylates, enlargement of the crystalloid as a result of azaserine and terephthalanilides, and extrusion of the nucleoid after hexahydrosalicylic acid or 140 THE JOURNAL OF CELL BIOLOGY · VOLUME 35, 1967 FIGURE 18 Male rat liver. Regeneration. Numerous microbodies (mb), most of them lacking a nucleoid, are present. They are commonly associated with narrow cisterns of agranular or pratially granulated membranes of endoplasmic reticulum (arrows). X 12,300.
sodium tungstate (19) . Dalton (8) suggested that the number of microbocdies was inversely related to the growth rate of hepatic tumors. Changes in the matrix of microbodies after thioacetamide (10) and numerical increase (21) as well as inhibition (13) after ethionine have been reported, and Confer and Stenger (22) demonstrated that in hepatic nodules induced in mice with carbon tetrachloride the microbodies were larger than normal and their nucleoids were enlarged and more complex. Afzelius (23) and Schnitka (5) showed quite consistent species' differences related to the presence and ultrastructure of crystalloid and noncrystalloid nucleoids in microbodies. Tsukada et al. (24) isolated nucleoids from rat liver and showed that they had urate oxidase activity 380 times higher than that of the whole homogenate. These authors suggested that in rat liver the nucleoids might be the only cytoplasmic particles in which urate oxidase is located. Similarly, de Duve, in ultracentrifugal studies that first defined the chemical composition of micIobodies (3), reported that catalase and D-amino acid oxidase were probably associated with the matrix of rat hepatic microbodies while urate oxidase was contained in the nucleoid or in the membrane. Verity et al. (25) found that, with stepwise purification of mouse liver homogenates, the fraction containing microbodies had a 20-fold increase in uricase activity. While the localization of urate oxidase in microbody nucleoids appears consistent in several instances, certain exceptions occur. For example, as pointed out by de Duve, the rat kidney lacks urate oxidase even though the renal microbodies contain amorphous but distinct central densities resembling nucleoids (6, 26) . (Fig. 26) . In addition, after CPIB many of the newly formed hepatic microbodies lack a nucleoid, and it is clear that the presence of a nucleoid is not necessarily a uniform finding in rat liver microbodies after treatment with this agent. Similarly, Biempica (27) showed that in a complex FIGtlE 19 Male rat liver. CPIB, 7 wk. Carbon tetrachloride 24 hr prior to sacrifice. The endoplasinic reticulunm (ER) is extensively dilated and contains fibrillar material. The internal structure of mitochondria (mi) is barely discernible, but the microbodies (mb) remain comparatively intact. X 9600.
disease state many microbodies of human liver acquired crystalloid nucleoids. While the hypolipidemic effects of clofibrate have been amply demonstrated in vivo in man and in lower animals, the mechanism of the pharmacological action is not definitely established at the present time. Platt and Thorp (28) attributed the primary effect of CPIB to displacement of thyroxine from serum protein and proposed that, as a consequence, there is a local, high concentration of thyroxine in the liver while the whole animal is relatively hypothyroid. In this context, the presence of propylthiouracil (0.3 %) in the thrombogenic diet may render untenable the present ultrastructural and biochemical observations made after the administration of this diet since this concentration of an antithyroid drug could, theoretically, interfere with the proposed pharmacological action of CPIB. Moreover, it was considered that the thrombogenic diet, high in fat, might be unpalatable to the rat and could account for a low consumption of this diet and CPIB. Though food intake in this group was initially below the average of control rats, after 3 days the consumption of the thrombogenic diet, with and without CPIB, was normal. The entire problem of the relationship of CPIB to thyroxine and microbody response is complex, and related experiments will be dealt with in greater detail in a separate report. 3 According to the proposal of Platt and coworkers (29) transaminase and glutamic pyruvate transaminase in man and in lower animals and related this finding to increase in lysosomal activity as reported by Paget (32) . It should be noted, however, that the increase in number of lysosomes and the formation of "giant lysosomes" as reported by Paget is difficult to verify from the illustrations. Although occasional lysosomes containing microbodies were evident in our experiments, these were rare and were not accompanied by any appreciable degree of focal cytoplasmic necrosis. In addition, CPIB administration to rats does not cause elevation of acid phosphatase activity in liver homogenates. 4 Hepatomegaly due to CPIB may not be strictly related to the microbody response or to changes in catalase activity induced by this agent. In our experiments, liver weight had returned almost to normal by 14 days after withdrawal of CPIB al- Male hamster liver. CPIB, 2 wk. The microbody (mb) contains two linear densities (d) forming an elongated nucleoid. X 66,000. though microbodies were still increased to an appreciable degree in many cells at that interval. Moreover, in female rats, liver weight increases after 0.25% CPIB (28) but there is no increase in microbodies in this sex at this dose. Similarly, although liver weight in young Rhesus monkeys increases after administration of CPIB for 3 months (28) , no increase in the number of microbodies occurs in a related species (squirrel monkey) at the dose used. Actinomycin D (10 pug/kg thrice weekly) given simultaneously with CPIB partially inhibited the microbody response and caused a decrease in catalase activity although liver weight increased. Admittedly, the comparison of liver weight to catalase activity is superficial, since several other factors must be considered. It has been shown previously (28) that the degree of change in liver weight as a result of CPIB is partially dependent on initial weight of the animals. Nevertheless, a general trend is apparent and comparison of these parameters seems valid in FIGURE 24 Male hamster liver. CPIB, 2 wk. Microbodies (mb), as well as mitochondria (mi), are in close apposition to large lipid vacuoles (L). X 28,800. FIGURE 25 Squirrel monkey liver. CPIB, 22 days. No increase in number and no abnormality in structure of microbodies are noted in this species. In contrast to microbodies of Rhesus monkeys, however, the microbodies of this species commonly contain irregular, ill defined nucleoids (n). X 28,800.
attempting a preliminary delineation of the pharmacological effects of CPIB and their relationship tomicrobodies, catalase, and liver weight.
The numerical assessment of the microbody population, from electron micrographs, bore a close relationship to catalase activity. The increased catalase levels most likely reflect the increased number of microbodies since 70-80% (3) of catalase is located in microbodies. Accordingly, it would be expected that a significant elevation in catalase activity would be reflected, in large part, by increase in size, number, and density of the microbodies. From two different approaches, one biochemical (3) and the other by quantitative assessments from electron micrographs (33) , it has been estimated that, in the normal rat liver cell, there are approximately four times as many mitochondria as microbodies. In the present experiments, quantitative evaluation of electron micrographs and comparison of the number of mitochondria to microbodies gave a mitochondria to microbody ratio of 1:1, an absolute increase clearly substantiated in semi-thin sections stained with azure-bicarbonate. The microbody response, with respect to both the increase in number of microbodies and increase in catalase levels, appears to reach a plateau at around 30 days and levels off thereafter despite continued CPIB in the diet. Though variations within the lobule in numbers of microbodies have been shown (7), in the present experiments a remarkable uniformity in number of microbodies was present in all blocks of liver regardless of their position in the lobule. Though many microbodies were atypical or aberrant, they were still identifiable either by the typical matrix density, size, and shape or by the presence of matrix striations. Novikoff and Shin (7) pointed out earlier that, even when the plane of section does not pass through the cores, microbodies are identifiable by size, shape, or degree of electron opacity. While one or two structural features were absent in some instances, the possession of the remaining characteristics served to identify the organelles with reasonable certainty.
Relationship of Microbodies t o Other Cell Organelles
Ericsson and Trump (6) and Ericsson (26) reported continuity of the limiting membrane of microbodies with smooth endoplasmic reticulum in the kidney, and several authors (1, 7, 11, 34) have shown continuity between microbodies and smooth endoplasmic reticulum in normal and pathological rat liver. In the kidney, Ericsson (26) reported a close relationship of microbodies to the Golgi apparatus. In the present experiments, not only were microbody attachments to smooth endoplasmic reticulum prominent in liver and kidney of the rat, but in liver of the mouse densities in dilated cisterns of smooth endoplasmic reticulum strongly suggested formation of microbody matrix material in specialized portions of smooth endoplasmic reticulum (Fig. 24) . In the regenerating liver, too, there was remarkably close apposition of microbodies to elongated profiles of incompletely granulated endoplasmic reticulum.
In addition to the topographical and biochemical (35, 36) association of microbodies to ergastoplasm, under certain circumstances microbodies are intimately related to lysosomes. After longterm administration of CPIB or after withdrawal of CPIB, microbodies are incorporated, along with other cellular materials, into single membranelimited bodies resembling lysosomes (Figs. 16-19 ). Bruni and Porter (37) suggested that microbodies were disposed of by fusion with lysosomes, but Novikoff and Shin (7) of microbodies is shown; neither has the typical structure of the microbody core been detected within a lysosome" (4) . Similarly, in the kidney, no transition forms were observed (6) . While no evidence of fusion of microbodies with lysosomes was found in the present experiments, microbodies with a core or nucleoid were present occasionally in lysosomes (Fig. 16 ). On the basis of quantitative estimates from numerous micrographs, however, it would appear that the occurrence of microbodies in lysosomes is too rare to account entirely for disposal of the excess microbodies in this manner, particularly between the 2nd and 3rd week after withdrawal of CPIB when 148 THE JOURNAL OF CELL BIOLORGY VOLUME 35, 1967 P value the number of hepatic microbodies is restored rapidly to normal. The structural concept of "focal cytoplasmic degradation" has been proposed to explain the removal of certain cytoplasmic constituents in the face of injury or adaptation to an altered metabolic state (38) . When one considers the occasional presence of microbodies within single membrane-limited structures, as observed in the present study, it seems probable that at least one mechanism for removal or digestion of microbodies is their incorporation into lysosomes. Presumably, microbodies segregated in this fashion are then hydrolyzed or incorporated into a residual body (38) (39) (40) . Alternatively, it is possible that destruction of most microbodies is accomplished by relatively rapid dissolution into the hyaloplasm, leaving no morphological "footprint" of their prior existence.
Biochemical Results
Several reviews have indicated numerous variables which influence catalase activity and have noted the lack of uniformity in assay methods and in expression of results of catalase assays (41) (42) (43) . Nonetheless, under controlled conditions and uniform method of assay, catalase activity generally was related to the number of microbodies in the same tissue when examined by electron microscopy. In contrast, uricase activity in the present experiments did not correspond to numerical changes in microbodies. In rats on CPIB for 10, 20, and 30 days, uricase levels decreased slightly, but the decrease was not significant and might be interpreted as a dilution effect due to the enlargement of the liver. In mice, the drop in uricase after CPIB for 5 months was slightly over 50%.
Species and Sex Differences
Most ultrastructural observations of microbodies have been made in rodents, but Schnitka (5), in several additional species, has illustrated precise differences in size, shape, and location of microbodies and to the presence and ultrastructure of the nucleoid. Similar species differences in the response of hepatic microbodies to CPIB are apparent from the present studies.
The absence of response in female rats to the dose of CPIB given in these experiments may be related to the natural difference of catalase levels in normal rodents (41, 44) , in which males have higher levels in kidney and liver than females do.
In the dog, CPIB causes an increase in liver weight in both sexes (28) but has no choleretic action (15) , and in perfusion experiments there is no penetration of CPIB into dog liver cells. Yet microbodies increase conspicuously in this species, suggesting that the entry of CPIB into cells and the observed effects on microbodies may not be related phenomena On the other hand, in most species which show a hypolipidemic effect of CPIB, there is a concomitant response in microbodies.
Although our earlier tentative interpretations (14) supported the hypothesis of Noviko-T and Shin (7) that microbodies were in some way related to lipid metabolism, in the present experiments other hypolidemic agents, notably 2,4-dichlorophenoxyacetic acid, which is structurally closely related to CPIB, did not cause increase in hepatic microbodies. It is apparent, therefore, that although in the case of CPIB the hypolipidemic effect may be related to microbodies, drug-induced hypolipidemia, in itself, is not a specific, sufficient, or general cause of increase in microbodies.
Afzelius (23) has reported that, in Rhesus monkeys, the presence or absence of a nucleoid had not been established. Whereas we found only rare nucleoids in microbodies in Rhesus monkeys, 2 in the squirrel monkey (Saimiri sciurea) irregular and indistinct nucleoids are frequently present. Moreover, in this species the microbodies are topographically associated with indentations of rough endoplasmic reticulum. In CPIBtreated animals, the microbody nucleoids do not appear to change in this species. It is thus apparent that variation occurs in different genera belonging to different superfamilies in the same suborder of mammals.
Regeneration
In regenerating liver the microbodies were increased to a degree comparable to that in rats given CPIB without partial hepatectomy, and the increase was similarly apparent in the entire lobule. Many of the cytological events accompanying liver regeneration and cell division in general have been reviewed previously (45) . In the context of the present experiments, it is apparent that regenerating cells are capable, to a degree comparable to nonregenerating cells, of producing microbodies in response to CPIB and that production of microbodies has a high biological priority in rapidly dividing cells. Similarly, in fetal mouse liver, it has been reported that microbodies are the first single membrane-limited bodies to appear and, with multivesicular bodies, constitute the only single membrane-limited bodies in prenatal life (46) . In other conditions involving rapid cell division, such as neoplasia (8) , the degree of microbody formation may be quite variable.
Cell Degeneration
In rats given carbon tetrachloride, the liver cells, by light microscopy, showed hydropic degeneration and, by electron microscopy, marked dilatation of the endoplasmic reticulum along with obliteration of most of the typical ultrastructural features of mitochondria. Despite these changes, however, the microbodies remained structurally intact. This is in accordance with de Duve's observations regarding the comparative stability of the limiting membranes of microbodies (4).
Inhibition of Microbody Proliferation
From the present experiments, it is evident that slight differences in doses of actinomycin D have markedly different effects on the catalase/microbody response to CPIB. Chloramphenicol, which inhibits protein synthesis (47), abolished completely the microbody response to CPIB. When one considers the fact that chloramphenicol inhibits protein synthesis by interfering with the growth of the nascent polypeptide chain (48) (though interference with protein synthesis at a more proximal step cannot be excluded at the present time) and the data of Higashi and Peters (35, 36) that indicate that catalase is first synthesized in the granular endoplasmic reticulum before concentration in microbodies, one would expect interruption of ribosomal function by chloramphenicol to result in aberrations in catalase synthesis and, consequently, in microbody formation. The observation that CPIB given simultaneously with a hypercholesterolemic thrombogenic diet fails to induce an appreciable increase in microbodies suggests that hyperlipidemia and increased liver fat inhibits or prevents the typical increase in hepatic microbodies due to CPIB. As previously indicated, however, the propylthiouracil present in the thrombogenic diet may be of importance in mitigating or opposing the effect of CPIB. In addition, since ordinarily the microbodies are
